论文部分内容阅读
近年来磷酸二酯酶抑制剂用于治疗哮喘重新引起了人们的极大兴趣,现阐述5种磷酸二酯酶同工酶及其选择性抑制剂治疗哮喘的理论基础和临床经验。
In recent years, phosphodiesterase inhibitors for the treatment of asthma re-attracted great interest in people, are now described five kinds of phosphodiesterase isoenzyme and selective inhibitors of the theoretical basis and clinical experience in the treatment of asthma.